Stay updated with breaking news from Mid Caps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press ReleaseNicox's Partner Ocumension Therapeutics Receives Priority Review Status for ZERVIATE New Drug Application in China Nicox's partner, Ocumension Therapeutics, announced on April
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Press ReleaseNew Data on Two Nicox's Assets, NCX 470 and NCX 1728, Presented at ARVO 2023April 26, 2023 - release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, COX), an
Investegate announcements from NICOX, Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
In the latest episode of “ETF 360,” VettaFi head of research Todd Rosenbluth spoke to Chad Miller of Thrivent Asset Management